Shares of Renalytix Plc (LON:RENX – Get Free Report) traded down 4.9% during trading on Monday . The company traded as low as GBX 8.60 ($0.11) and last traded at GBX 8.80 ($0.12). 2,423,027 shares changed hands during mid-day trading, an increase of 60% from the average session volume of 1,518,707 shares. The stock had previously closed at GBX 9.25 ($0.12).
Renalytix Trading Down 4.9%
The stock has a market cap of £35.67 million, a price-to-earnings ratio of -55.00 and a beta of 2.10. The company has a quick ratio of 2.42, a current ratio of 0.24 and a debt-to-equity ratio of -72.91. The business’s 50 day simple moving average is GBX 7.36 and its 200 day simple moving average is GBX 7.52.
Renalytix Company Profile
Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S.
Featured Articles
- Five stocks we like better than Renalytix
- Industrial Products Stocks Investing
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- Insider Buying Explained: What Investors Need to Know
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
